期刊文献+

376例心肌梗死患者受体阻滞使用情况的调查分析

下载PDF
导出
摘要 目的初步了解本地区β-受体阻滞剂使用情况与指南要求差距,以进一步指导临床实践。方法制定入选患者标准,调查376例2002~2006年5年住院的心肌梗死患者中使用β-受体阻滞的资料。结果2002~2006年5个年度,心肌梗死患者β-受体阻滞剂使用率有逐年增高趋势,5年比较有统计学差别。结论随着对心肌梗死病理生理过程的认识和循证医学展示β-受体阻滞剂在心肌梗死治疗中占重要地位,其实际中应用跟指南要求的有较大差距,更加合理规范应用,仍是亟待解决的问题。
出处 《中国实用医药》 2007年第33期73-74,共2页 China Practical Medicine
  • 相关文献

参考文献5

  • 1[1]Yusuf S,Peto R,Lewis J,et al.Beta blockade during and after myocardial infarction:an overview of the randomized trials.Prog Cardiovasc Dis,1985,2:335-371.
  • 2[2]Frishman WH,Cheng A.Secondary peevention of myocardial infarction:Role of beta-adrenergic blockers and angiotensincoverting enzyme inhibitors.Am Hesrt J,1999,137:25-34.
  • 3[3]Krumholz HM,Radlford MJ,et al.Early beta-blocker therapy for acute myocardial infarction in elderly patients.Ann intern Med,1999,131:648-654.
  • 4[5]Stephen S,Gottlieb,Robert J//Effect of Beta-blocters on mortality among hing-risk and low-risk patients after myocardial infarction.New Engl J Med,1998,339:489-497.
  • 5蒋立新,陈铮鸣,谢晋湘,Rory Collin,Richard Peto,刘力生.中国急性心肌梗死和梗死后2级预防治疗状况调查[J].临床心血管病杂志,2002,18(9):417-420. 被引量:30

二级参考文献6

  • 1[1]Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rational, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. J Cardiovasc Risk,2000,7:435-441.
  • 2[2]ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet,1995,345:669-685.
  • 3[3]Antman E M, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA,1992,327:248-254.
  • 4[4]The Heart Outcome Prevention Evaluation (HOPE) Study Investigator. Effects of an angiotensin-converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med,2000,342:145-153.
  • 5[5]Freemantle N, Cleland J, Young P, Harrison, et al. b-blockade after myocardial infarction: Systematic review and meta regression analysis. BMJ,1999,318:1730-1737.
  • 6[6]MRc/BHF Heart Protection Study Collaborative Group. Randomized trial of cholesterol-lowering with simvastatin in a wide range of patients at increased risk of vascular disease. Lancet ,2002,360:7-22.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部